Published in Eur J Obstet Gynecol Reprod Biol on December 08, 2006
Individual management of cervical cancer in pregnancy. Arch Gynecol Obstet (2016) 0.76
Treatment and prognosis of cervical cancer associated with pregnancy: analysis of 20 cases from a Chinese tumor institution. J Zhejiang Univ Sci B (2015) 0.75
Cervical Carcinoma in Early Pregnancy - Successful Birth by Caesarean Section Followed by Radical Hysterectomy. Geburtshilfe Frauenheilkd (2014) 0.75
[Management of cervical cancer during pregnancy: report of 05 cases]. Pan Afr Med J (2014) 0.75
Malignant effusions and immunogenic tumour-derived exosomes. Lancet (2002) 4.91
Cutaneous side-effects of kinase inhibitors and blocking antibodies. Lancet Oncol (2005) 2.85
Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area. J Clin Oncol (2008) 2.23
Cyclophosphamide induces differentiation of Th17 cells in cancer patients. Cancer Res (2010) 2.12
Gynaecological cancers in pregnancy. Lancet (2012) 2.11
Outcomes after combined therapy including surgical resection in patients with epithelial ovarian cancer recurrence(s) exclusively in lymph nodes. Ann Surg Oncol (2004) 1.75
Recommendations for image-based intracavitary brachytherapy of cervix cancer: the GYN GEC ESTRO Working Group point of view: in regard to Nag et al. (Int J Radiat Oncol Biol Phys 2004;60:1160-1172). Int J Radiat Oncol Biol Phys (2005) 1.75
Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy. Radiother Oncol (2012) 1.54
Prognostic factors of a large retrospective series of mucinous borderline tumors of the ovary (excluding peritoneal pseudomyxoma). Ann Surg Oncol (2010) 1.53
Exclusive radiotherapy for primary squamous cell carcinoma of the vagina. Radiother Oncol (2007) 1.50
Clinical recommendation radical trachelectomy for fertility preservation in patients with early-stage cervical cancer. Int J Gynecol Cancer (2012) 1.49
Results after laparoscopic management of serous borderline tumor of the ovary with peritoneal implants. Gynecol Oncol (2005) 1.49
Prognostic impact of vitamin B6 metabolism in lung cancer. Cell Rep (2012) 1.45
Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications. J Am Coll Surg (2003) 1.40
First case of a centropelvic recurrence after radical trachelectomy: literature review and implications for the preoperative selection of patients. Gynecol Oncol (2004) 1.37
Malignant transformation of abdominal wall endometriosis to clear cell carcinoma: case report and review of the literature. Fertil Steril (2007) 1.22
Guidelines for the management of ovarian cancer during pregnancy. Eur J Obstet Gynecol Reprod Biol (2009) 1.18
Inter-observer comparison of target delineation for MRI-assisted cervical cancer brachytherapy: application of the GYN GEC-ESTRO recommendations. Radiother Oncol (2008) 1.18
MRI-based low dose-rate brachytherapy experience in locally advanced cervical cancer patients initially treated by concomitant chemoradiotherapy. Radiother Oncol (2010) 1.18
Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study. Radiother Oncol (2012) 1.17
Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients. Int J Radiat Oncol Biol Phys (2008) 1.17
Common strategy for adult and pediatric medulloblastoma: a multicenter series of 253 adults. Int J Radiat Oncol Biol Phys (2007) 1.16
Results of interval debulking surgery compared with primary debulking surgery in advanced stage ovarian cancer. J Am Coll Surg (2003) 1.13
Nodal-staging surgery for locally advanced cervical cancer in the era of PET. Lancet Oncol (2012) 1.08
Para-aortic involvement and interest of para-aortic lymphadenectomy after chemoradiation therapy in patients with stage IB2 and II cervical carcinoma radiologically confined to the pelvic cavity. Ann Surg Oncol (2007) 1.08
Long-term results of brachytherapy for carcinoma of the penis confined to the glans (N- or NX). Int J Radiat Oncol Biol Phys (2009) 1.07
Conservative management of low-grade endometrial stromal sarcoma followed by pregnancy and severe recurrence. Anticancer Res (2009) 1.05
Prognostic factors and morbidities after completion surgery in patients undergoing initial chemoradiation therapy for locally advanced cervical cancer. Oncologist (2010) 1.05
Fibrogenic signals in patients with radiation enteritis are associated with increased connective tissue growth factor expression. Int J Radiat Oncol Biol Phys (2003) 1.04
Growing teratoma syndrome after ovarian germ cell tumors. Obstet Gynecol (2006) 1.02
[Role of radiotherapy in recurrent gliomas]. Bull Cancer (2004) 1.00
Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options. Hum Reprod Update (2012) 1.00
Clinical practice guidelines for the management of patients with endometrial cancer in France: recommendations of the Institut National du Cancer and the Société Française d'Oncologie Gynécologique. Int J Gynecol Cancer (2011) 1.00
Maximal cytoreduction in patients with FIGO stage IIIC to stage IV ovarian, fallopian, and peritoneal cancer in day-to-day practice: a Retrospective French Multicentric Study. Int J Gynecol Cancer (2012) 0.99
New trends in the evaluation and treatment of cervix cancer: the role of FDG-PET. Cancer Treat Rev (2008) 0.99
Malignant female adnexal tumor of probable wolffian origin relapsing after pregnancy. Gynecol Oncol (2004) 0.98
Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting. Int J Gynecol Cancer (2014) 0.98
Targeting the deregulated spliceosome core machinery in cancer cells triggers mTOR blockade and autophagy. Cancer Res (2013) 0.98
Impact of surgical staging in patients with macroscopic "stage I" ovarian borderline tumours: analysis of a continuous series of 101 cases. Eur J Cancer (2004) 0.96
DVH parameters and outcome for patients with early-stage cervical cancer treated with preoperative MRI-based low dose rate brachytherapy followed by surgery. Radiother Oncol (2009) 0.96
Intercomparison of treatment concepts for MR image assisted brachytherapy of cervical carcinoma based on GYN GEC-ESTRO recommendations. Radiother Oncol (2006) 0.95
[Peritoneal glioblastoma: recurrence of ovarian immature teratoma (report of a case)]. Ann Pathol (2002) 0.95
Parametrial boost using midline shielding results in an unpredictable dose to tumor and organs at risk in combined external beam radiotherapy and brachytherapy for locally advanced cervical cancer. Int J Radiat Oncol Biol Phys (2010) 0.94
Results after conservative treatment of serous borderline tumors of the ovary with a micropapillary pattern. Ann Surg Oncol (2008) 0.94
Primary psammocarcinoma of the ovary or peritoneum. Int J Gynecol Cancer (2009) 0.94
Lymph node disorders and prognostic value of nodal involvement in patients treated for a borderline ovarian tumor: an analysis of a series of 42 lymphadenectomies. J Am Coll Surg (2002) 0.94
Laparoscopic radical hysterectomy for invasive cervical cancer: 8-year experience of a pilot study. Gynecol Oncol (2003) 0.93
A randomized phase II trial of maintenance therapy with Sorafenib in front-line ovarian carcinoma. Gynecol Oncol (2013) 0.92
Overview of brachytherapy resources in Latin America: a patterns-of-care survey. Brachytherapy (2011) 0.92
Impact of infertility drugs after treatment of borderline ovarian tumors: results of a retrospective multicenter study. Fertil Steril (2006) 0.92
Gynecologic Cancer InterGroup (GCIG) consensus review: uterine and ovarian leiomyosarcomas. Int J Gynecol Cancer (2014) 0.91
Technical aspects and perspectives of the vaginal mold applicator for brachytherapy of gynecologic malignancies. Brachytherapy (2010) 0.91
Phase I clinical trial combining imatinib mesylate and IL-2: HLA-DR(+) NK cell levels correlate with disease outcome. Oncoimmunology (2013) 0.91
Prognostic value of lymph node involvement in ovarian serous borderline tumors. Am J Obstet Gynecol (2011) 0.90
Prognostic factors in women treated for ovarian yolk sac tumour: a retrospective analysis of 84 cases. Eur J Cancer (2010) 0.90
Prognosis and prognostic factors of the micropapillary pattern in patients treated for stage II and III serous borderline tumors of the ovary. Oncologist (2011) 0.90